EULAR EMEUNET

Peresolimab in RA – new name, new pathway, new opportunity? - With Dr. Jay Tuttle

EULAR EMEUNET

Show Notes

Join Philipp Bosch and Pierre-Antoine Juge as they discuss hot topics in rheumatology with special guests. This week an interview with Dr. Jay Tuttle.

This PD-1 inhibitor was investigated by Dr. Tuttle and his team in a phase 2a RCT published in the NEJM. Dr. Tuttle also share about his career in the industry and how he is now responsible for developing clinical trials!

Editorial Team: Dr Renske Meijer, Dr Bayram Farisogullari, Dr Olivier Fakih, Dr Mrinalini Dey.

More from EULAR EMEUNET

Oct 8, 2026

💚 This World Arthritis Day, we’re celebrating the many different ways people living with rheumatic and musculoskeletal diseases (RMDs) can continue to pursue their dreams. In this special podcast episode, three guests discuss how dreams can evolve when living with an RMD, how circumstances can shape opportunities and goals, and why successful care should look beyond disease activity to what matters most in a person’s life. Hosted by Nele Caeyers, featuring Prachee Bhosle and Sophia Marantido...

Sep 1, 2026

Join Cristiana Sieiro Santos, Ufuk Ilgen and Daliya Pencheva as they discuss the important role Country Liaisons play in connecting early-career rheumatologists across Europe, promoting EMEUNET opportunities at the national level, strengthening collaboration with national societies, and supporting educational and networking initiatives. We also hear about the development of the Country Liaison Recognition Award and the experience and achievements of its first recipient, including advice for t...

Jul 1, 2026

Listen to three of the Top 10 EMEUNET Abstract Award winners as they share the research behind their award-winning abstracts, recorded live at the EULAR 2026 Congress in London. From real-world outcomes in psoriatic arthritis to AI in patient education and innovative approaches to assessing disease activity in myositis, discover the stories behind the science and the latest research shaping the future of rheumatology.

Jun 23, 2026

🎧 Hear from RheumaVision 2026 finalists Vilde Øverlien Dåstøl, Kabir Budlender, and Mariia Sobchenko as they reflect on their projects, inspirations, and hopes for the future of rheumatology.

May 8, 2026

Inside Rheumavision Join Olivier in conversation with Cristiana Sieiro Santos and two semi-finalists from the second edition of Rheumavision 2026.

See all episodes →